West Pharmaceutical Services (STU:WPS) ROE % Adjusted to Book Value : 2.57% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is West Pharmaceutical Services ROE % Adjusted to Book Value?

West Pharmaceutical Services's ROE % for the quarter that ended in Sep. 2024 was 20.11%. West Pharmaceutical Services's PB Ratio for the quarter that ended in Sep. 2024 was 7.83. West Pharmaceutical Services's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 2.57%.

West Pharmaceutical Services ROE % Adjusted to Book Value Historical Data

The historical data trend for West Pharmaceutical Services's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services ROE % Adjusted to Book Value Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.36

1.78

2.22

3.72

2.38

West Pharmaceutical Services Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															2.37	2.13	1.56	1.84	2.57

Competitive Comparison of West Pharmaceutical Services's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

West Pharmaceutical Services's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's ROE % Adjusted to Book Value falls into.

West Pharmaceutical Services ROE % Adjusted to Book Value Calculation

West Pharmaceutical Services's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.02%	/	8.84
	=	2.38%

West Pharmaceutical Services's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	20.11%	/	7.83
	=	2.57%

West Pharmaceutical Services ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (STU:WPS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

WST:USA WST:Mexico WPS:Germany W2ST34:Brazil

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-1147

Website

https://www.westpharma.com

West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.